US, Canada and Brazil intragastric balloons market estimated to reach USD 66.94 million
The collective US, Canada and Brazil intragastric balloon market is estimated to reach USD 66.94 million by 2023. The market was valued at USD 38.72 million in 2015. It is estimated that in 2017, obesity will cost the European Union USD 78.09 billion annually through healthcare costs and lost productivity. The US is one with the countries that has the highest rate of obesity. Factors such as presence of a large obese population change in lifestyle, reduced hospital stay, short recovery time, and availability of low-priced Intragastric balloons is driving the growth of the market. However, limitations and adverse events of Intragastric balloons are likely to limit the adoption of this technology. The Intragastric balloons market is highly competitive with presence of large, medium, and small players. Some of the major players in this market are Apollo Endoscopy, Spatz FGIA, Allurion Technologies, ReShape Medical, Hélioscopie and Obalon Therapeutics.
